ERBB2 and neoplasm: The formation of HER2 homodimers leads to the phosphorylation of the tyrosine kinase domain, thereby activating various downstream cancer signaling pathways, ultimately enhancing cancer cell proliferation, tumor formation, invasion, and related processes [7,8].